European Medicines Agency (EMA) Commentary on EMA / CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations

Andreas Bonertz; Catherine Drai; Diana Hartenstein; Susanne Kaul; Milica Mitrevski; Jose Zubeldia

doi:10.22541/au.174048690.00012898/v1

loading page

European Medicines Agency (EMA) Commentary on EMA / CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations

Andreas Bonertz,
Catherine Drai,
Diana Hartenstein,
Susanne Kaul,
Milica Mitrevski,
Jose Zubeldia

24 Feb 2025Submitted to British Journal of Clinical Pharmacology

Show details

Hide details

25 Feb 2025Submission Checks Completed

25 Feb 2025Assigned to Editor

25 Feb 2025Review(s) Completed, Editorial Evaluation Pending

05 Mar 2025Editorial Decision: Accept

Peer review status:ACCEPTED